These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 924590)

  • 21. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
    Kanra G; Ceyhan M
    Turk J Pediatr; 1991; 33(4):217-20. PubMed ID: 1814038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 25. Negative seroconversion and circulating interferon in children vaccinated with live measles vaccine.
    Izbický A; Drevo M; Domorázková E; Slonin D
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(2):191-4. PubMed ID: 562373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with a measles vaccine manufactured in India.
    Shaikh N; Raut SK; Bedekar SS; Phadke MA; Banerjee K
    Indian Pediatr; 1992 Jul; 29(7):883-7. PubMed ID: 1428138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
    Lin M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):138-40. PubMed ID: 1423535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Post-vaccination measles immunity in children on long-term anticonvulsant therapy].
    Popović-Miocinović L; Smerdel S; Grubesić Z; Miklousić A
    Lijec Vjesn; 1994; 116(3-4):74-8. PubMed ID: 8057741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 31. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serological evidence of persistent elimination of measles in Czechoslovakia].
    Strauss J; Svandová E; Smelhausová M; Mrázová M
    Cas Lek Cesk; 1989 Mar; 128(13):399-403. PubMed ID: 2790867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
    Narayan KM; Moffat MA
    Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination of seropositive children against measles in Tanzania: boosting of antibody titres or a statistical artifact.
    Mandara MP; Remme J
    East Afr Med J; 1985 Jan; 62(1):12-20. PubMed ID: 4006810
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G; Petersen I; Mordhorst CH
    Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiology of measles in Delhi: implications for age of vaccination.
    Khare S; Dutta A; Kumari S; Basu RN
    Indian J Pediatr; 1987; 54(5):711-5. PubMed ID: 3501410
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy of specific prophylaxis against measles].
    Andzhaparidze OG; Gordienko HM; Sokolova TM; Dorofeev VM
    Vestn Akad Med Nauk SSSR; 1975; (4):27-33. PubMed ID: 1220365
    [No Abstract]   [Full Text] [Related]  

  • 40. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL
    Tr Inst Im Pastera; 1979; 53():75-8. PubMed ID: 162466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.